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A. ABSTRACT 
Mineral trioxide aggregate (MTA) is a modified Portland cement (PC) based dental 
material containing bismuth oxide (Bi2O3) as a radiopacifier that is presently used as 
a sealing material in endodontic treatment. The present study investigated the 
influence of albumin, fibrinogen and γ-globulin, the three most abundant blood 
plasma proteins, both individually and in combination on the setting time, 
compressive strength and relative porosity of an MTA-like dental cement. The 
cement powder formulation was mixed with the liquid phase containing normal 
plasma protein concentrations or quarter, double or quadruple the normal plasma 
protein concentration as well as a mixture of all three proteins. Compressive strength 
and relative porosity were measured from 2 to 56 days and the initial setting times 
were determined using the Gilmore needles test. The set cement microstructure was 
examined using scanning electron microscopy (SEM) and energy dispersive X-ray 
spectroscopy (EDX). The compressive strength of all cements increased with time 
whereas strut density and relative porosity decreased. Fibrinogen and γ-globulin 
increased setting time with increasing concentration while albumin acted as an 
accelerant. For the MTA model mixed with all three plasma proteins, the setting times 
decreased as concentrations were increased. 
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CHAPTER 1 -  INTRODUCTION 
1.1 Basics of endodontics 
“Endodontics may be defined as the branch of dental science concerned with the 
study of form, function, health of, injuries to and diseases of the dental pulp and 
periradicular region and their treatment”.1 In endodontic practice diagnosis and 
treatment of dental pain and disease are considered to be fundamental in order for 
the tooth to function as a unit within the dental arch.2 
Irritation or injury is often the cause of inflammation of the pulp, which can arise most 
commonly either from bacterial or mechanical irritation. Bacterial causes are from 
dental caries or decay, whilst mechanical irritation may be caused by tooth 
repositioning, operative procedures or trauma.3  
1.1.1 Dental caries  
Dental caries is the medical term for tooth decay or development of a cavity within a 
tooth. It is a process which arises on the tooth surface, where a microbial biofilm 
(dental plaque) develops over a period of time if not brushed or cleaned away. 
Streptococcus mutans is one of the bacteria which plays a significant role in the 
carious process, as it metabolises sugar in the food into acid, which then dissolves 
hydroxyapatite in the tooth structure. 
The acid attacks the enamel which starts to break down forming a physical defect in 
the surface of the tooth. Following these food particles became trapped in the cavity 
which cannot be cleaned by brushing. For this reason a destructive process is more 
likely to progress and the acid dissolves the dentine and the patient may feel mild 
pain with sweet, hot and cold food or drink. This is due to movement of dentinal fluid 
caused by the change in temperature or osmotic pressure change inducing the nerve 
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fibres within the pulp chamber to elicit pain sensations. Treatment in this case is to 
remove decayed material from the cavity and then to replace lost tooth tissue with an 
appropriate restoration.4 
If the tooth is left untreated, caries will ultimately reach the pulp, which will be 
infected by bacteria possibly causing an abscess. In this case the patient may feel 
sharp pain often being initiated by hot or cold drinks. In this situation, the tooth 
requires either endodontic treatment or extraction. 5    
1.1.2 Diagnosis  
Diagnosis of the disease can be made from patient symptoms and clinical findings. 
Caries, trauma and abrasion will cause a patient to experience some pain, however, 
with the course of time this will eventually cease. This pain can be reignited by hot 
and cold drinks or sweets that stops on removal of the stimulus. Generally there will 
be no pain felt on biting and the periapical radiographic findings will usually be 
normal. The treatments for such cases is to remove the caries and restore the tooth 
with a suitable filling. The consequence of an untreated carious tooth, may lead the 
patient to develop irreversible pulpitis and cause spontaneous pain which could last 
from minutes to hours. The tooth will require either endodontic treatment or 
extraction. Ultimately, irreversible pulpitis (pulpitis that cannot recover) leads to pulp 
necrosis (death of the pulp) if left untreated will lead to periapical inflammation 
causing the patient to develop pain on chewing, typically eliciting no response to 
sweet, hot or cold stimulus. The treatment for pulp necrosis is the same as for 
irreversible pulpitis, root canal treatment (RCT) or extraction of the affected tooth.3 
Generally, the objective of RCT is to clean the infected pulp cavity and remove toxic 
debris and thereafter shape the root canal to enable it to receive a filling material. 
3 
 
The purpose of the filling material is to seal the whole root canal system from the 
periodontal tissues as well as the oral cavity. 3 
1.1.3 Preparation of the root canal system 
There are generally only two approaches commonly recognized for root canal 
preparation, either orthograde (approaching via the crown of the tooth) or retrograde 
(approaching surgically via apical tissues). However, if it is not possible to prepare 
the entire length of the root canal then the surgical approach may be used to seal the 
canal system from the periapical tissues.2  
RCT starts by gaining access to the pulp chamber through the occlusal or incisal 
surfaces and establishes the correct outline shape to gain access to the orifices of 
the root canals, using a high speed hand-piece that subsequently enables removal of 
the entire contents and allows inspection of the pulp chamber floor. The procedure of 
cleaning and shaping the root canals are carried out by hand as well as rotary 
instruments and bactericidal irrigation solutions such as 2.5% sodium hypochlorite 
solution are extensively used. The purpose of cleaning the root canals is to remove 
bacteria and any bacterial products or related irritants. This is achieved by intracanal 
irrigation and instruments such as rotary instruments or files which are positioned 
near the apex and then withdrawn while simultaneously scraping along the wall of the 
root canal when some binding is felt. A continuous tapering shape creates adequate 
space during canal enlargement to receive intracanal medicaments.6 The procedure 
of irrigation is in essential cleaning and shaping the root canal as it washes away 
pulpal debris and dentine chips and also aids in lubricating endodontic instruments 
and facilitates the cutting action of the files. To establish the apical extent of 
instrumentation and the ultimate level of root canal filling, it is important to first 
establish exact working length of the canal which should be at the apical foramen. 
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This is done by means of a radiograph or by an electronic measuring device.2 Prior to 
a root filling being inserted, the tooth must be asymptomatic and the root canal in a 
dry condition. The aim of root canal obturation is to immobilise any remaining 
bacteria with a hermetic seal in the canal from the coronal to the apical aspect of the 
tooth so that the remaining bacteria are in an environment where proliferation and 
surviving not possible. Apart from the apical seal which is essential, much emphasis 
has recently been placed on the need for a coronal seal as contamination can arise 
coronally particularly from saliva. Contamination of the root canal filling which could 
lead to failure may take place due to a poor coronal seal.7 
1.1.4 Endodontic perforations 
Endodontic perforations are a communication between the root canal space and the 
periodontal space caused iatrogenically while undertaking endodontic treatment. 
Perforations can have several different causes such as restorative defects, caries, or 
iatrogenic events (which are usually caused by a dentist‟s treatment of a patient) 
these can happen both during and after endodontic treatment. Whatever the cause 
may be, in the early stage of a perforation it cause inflammation, destruction of the 
periodontal tissues and loss of sulcular attachment after having invaded the 
supporting structures and ultimately the chance of successful treatment is reduced.9 
In the event of perforations a decision must be reached by the treating clinicians as 
to what course of treatment to take, either extraction or decide to leave the tooth in 
place for a surgical correction, nonsurgical treatment or a combination of the two. 
Treatment selection and prognosis are affected by a number of factors, including the 
length of time the perforation has been present in the tooth, severity of infection, size 
of perforation and relationship to the gingival margin. To prevent further loss of 
attachment and sulcular breakdown urgent attention must be given to repairing and 
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sealing the perforation hermetically. It is usually easier to deal with smaller 
perforations compared with larger ones. Furthermore, the chances of success in 
treatment are higher in the more apical perforations. 10 
Perforation repair can be achieved intracoronally and/or by an external surgical 
approach. The essential aspect in both approaches is to achieve a hermetic seal 
between the tooth and the material that is being used for the repair. This is 
determined by several important factors, namely, location and size of the perforation, 
operator skill and the physical and chemical characteristics of the repair material. 8 
An ideal endodontic repair material would adhere to the tooth structure, be 
dimensionally stable, fill canal irregularities and lateral canals (which are canals that 
lie perpendicular to the main root canal and can be found anywhere along the length 
of the root). The material also needs to have adequate sealing properties, be 
insoluble in tissue fluids, non-resorbable, radiopaque and demonstrate 
biocompatibility with human tissues.2,11,12,13 
1.2 Endodontic filling materials  
1.2.1 Materials used in endodontics  
Amalgam had once been the material of choice for retrograde fillings as a 
consequence of its relatively easy handling, being radiopaque, non-soluble in tissue 
fluids and the sealing improves as the amalgam ages and corrodes, due to the 
corrosion products generating a barrier to fluid flow around the amalgam. However, 
amalgam has some disadvantages, namely dimensional instability and a slow setting 
time. Amalgam also needs an undercut in the cavity preparation for retention which 
reqires the removal of even more tooth tissue. Hard and soft tissues can also 
become stained by silver following amalgam use in the surrounding tissues which 
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can cause a tattoo.14 Anderson et al. (1991) reported that microleakage of amalgam 
was reduced greatly by the usage of AmalgambondTM which is a self-cured bonding 
agent for the placement of direct restorations using amalgam.15  
 
Another endodontic root filling material, zinc oxide-eugenol (ZOE) has the 
weaknesses of long setting time and high water solubility which were observed when 
used for retrograde fillings.9 The use of ZOE as a root-end cement in periradicular 
surgery has not been extensively reported, but recent modifications of ZOE 
compounds, such as zinc oxide-eugenol with polymer reinforcement (IRM) and 
(Super EBA) provide a better seal. 16 Super EBA (32% eugenol and 68% ethoxy 
benzoic acid) is a zinc oxide-eugenol cement modified with ethoxybenzoic acid to 
decrease the setting time and increase its strength. Therefore it has several 
advantages over ZOE, is nonresorbable, radiopaque, has a neutral pH and low 
solubility. Even in a moist environment, Super EBA adheres to the tooth structure 
and is easy to use 16. However, difficulty in placing and compacting may be 
experienced with Super EBA as it adheres to all surfaces and has a short setting 
time. 9  
Glass ionomer cement (GIC) is formed by the reaction of calcium–aluminosilicate 
glass particles with aqueous solutions of polyacrylic acid. GIC bonds physico-
chemically to the dentine surface. Callis et al. (1987) showed that there was a 
cytotoxic effect in freshly mixed samples, although toxicity decreased with time.17 On 
the other hand, MacNeil  et al. (1987) reported that during the placement of GIC, its 
properties are affected when the root end is contaminated with moisture as the 
imbibitions of water changes the properties of GIC decreasing its ability to create an 
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adequate seal.18 Use of acidic conditioners and varnishes improves marginal 
adaptation and adhesion of glass ionomer cements to dentine.17 
Chong et al. (1991) reported using a light cured, resin reinforced GIC as a retrograde 
filling material and found that the reinforced GIC demonstrated the least 
microleakage due to a decreased moisture sensitivity, less curing shrinkage and a 
deeper penetration of the polymer into the dentine surface19.  
Calcium phosphate cement (CPC) is a mixture of two calcium phosphate compounds 
which was developed at the ADA-Paffenbarger Dental Research Center in the United 
States5. The most common variant is composed of dicalcium phosphate and 
tetracalcium phosphate reactants reacting isothermally to form a solid implant 
composed of hydroxyapatite when mixed with water 20. The set cement consists of a 
crystalline material and porosity depends on the quantity of the aqueous phase. It is 
a radiopaque material and does not cause a continuous inflammatory or toxic 
reaction22. CPC has been shown to wet the dentinal walls well and the formation of 
hydroxyapatite as a product of the setting process is also considered advantageous 
as it is well tolerated by vital tissue. 
In addition to plugging the apical foramen CPC has been shown to penetrate into the 
dentinal tubules in a scanning electron microscopic study.21 
The compressive strength of CPC can be higher than 60 MPa and has been shown 
to maintain its form and volume over time. An in vivo study in monkeys found new 
bone developing immediately adjacent to the CPC22. The biomaterial CPC has been 
shown to have excellent biological properties and an acceptable mouldable property 
but appears to lack in mechanical properties therefore limiting its biological 
application.23 
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Calcium hydroxide cement consists of an activator paste made of calcium hydroxide, 
zinc oxide and zinc stearate in ethylene toluene sulphonamide, whilst  the base paste 
is composed of calcium hydroxide cement contains calcium tungstate, calcium 
phosphate and zinc oxide in glycol salicylate. 24 
Calcium hydroxide cement is used in clinical application as an apical plug, root canal 
sealer and for both capping of an exposed pulp (direct pulp capping) and nearly 
exposed pulp (indirect pulp capping). The cement is also used as a protective barrier 
against external influences like bacteria and to encourage healing, so that beneath 
composite restorations the material does not interfere with the polymerisation of the 
composite. In addition, calcium hydroxide is routinely used as a dentine desensitizing 
agent in order to reduce dentine permeability, either by physical blockage of the 
tubule orifices and stimulation of secondary dentine.25 The cements have an alkaline 
pH which varies from 11 to 12. For these cements a fast setting time varying from 2 
up to 7 minutes and a compressive strength at one day of 26 MPa was found. The 
products of the cements greatly differ in their degrees of solubility in water and acid.24  
 
1.2.2 Mineral trioxide aggregate (MTA)  
 Mineral trioxide aggregate (MTA) is a modified Portland cement containing a 
radiopacifier.26 Torabinejad et al.  (1993) developed MTA as a root-end filling material 
for periapical surgery and for the sealing of contact between the root canals and the 
surrounding tissues27. One of the major applications of MTA is its use as a retrograde 
filling material and for perforation repair. In the early 1990s scientists undertook an 
investigation into MTA to evaluate its use for root canal treatment. In 1998, the U.S 
Food and Drug Administration approved the use of MTA and it became commercially 
available as ProRoot MTA (Tulsa Dental Product, USA). Recently different types of 
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MTA have become available including grey and white forms and also from a different 
manufacturer, MTA-Anglus (Angelus Solucoes Odontologicas, Londrina, Brazil).23 
1.2.2.1 Chemical and physical properties of MTA  
The raw constituents of Portland cement (PC) are calcium oxide (CaO), silicon 
dioxide (SiO2), alumina (Al2O3) and iron oxide (Fe2O3). When these raw materials are 
mixed, crushed and then heated up to 1400-1600oC with added gypsum 
(CaSO4
.4H2O) to control the setting time, the resulting product consists of tricalcium 
silicate (3CaO.SiO2), dicalcium silicate (2CaO
.SiO2), tricalcium aluminate 
(3CaO.Al2O3) and tetracalcium aluminoferrite (4CaO
.Al2O3
.Fe2O3)
23,28. MTA is a 
mixture of 75 wt% PC, 20 wt% bismuth oxide (Bi2O3) radiopacifier to enable 
radiographic assessment of the cement and 5 wt% calcium sulphate as a setting 
modifier.29,30 In addition, MTA has a smaller particle size compared with PC and is an 
expensive material16 . Torabinejad et al. (1995) showed that within 4 to 6 hours a 
solid cement structure forms as a result of colloidal gel solidification after hydration of 
the powder.31 Coomaraswamy et al. (2007) reported that the compressive strength of 
an MTA model system after ten days in an incubator at 37oC was 36 MPa, the 
relative porosity was 23% and strut density 2.76 g/cm3, compared with the 
commercial MTA which had a compressive strength of 33 MPa, relative porosity of 
31% and a strut density of 2.74 g/cm3.30 
In comparison with zinc oxide eugenol (ZOE) and amalgam, MTA has a shorter 
setting time in a moist environment, better dimensional stability and also generates a 
better seal32. Peter et al. (2002) found that MTA has a significantly better adaptation 
to dentinal walls at the apex of the root than either amalgam or ZOE after submitting 
all three materials to a computer controlled simulated masticating device that 
produced an estimated 5 year equivalence of chewing cycles.33  
10 
 
1.2.2.2 Microleakage 
The measure of success for any root canal treatment is the endodontic material‟s 
ability to adequately seal, as the vast majority of post-treatment endodontic problems 
are thought to arise as a consequence of unobturated and uncleaned apical areas of 
the root canal system, which then egress into the surrounding tissues and cause the 
whole root canal treatment to fail.  
Torabinejad et al. (1993) has undertaken studies on the micro-leakage of MTA via in-
vitro dye and fluid filtration methods comparing MTA with other traditional root canal 
materials in order to identify the advantages and disadvantages of MTA. MTA has 
been reported to have less micro-leakage than amalgam, ZOE or a conventional GIC 
when used for root-end restoration. 34,35 
In an investigation by Lamb et al. (2003) it was found that the minimal thickness for 
MTA to effectively seal the apical area should be at least 3mm.36    
When used as a perforation repair material, MTA did not demonstrate any bacterial 
leakage during a 45-day evaluation while half of the amalgam-repaired perforation 
allowed bacterial penetration.37  
Whilst providing the protection comparable with that of ZOE used for repair of 
furcation perforations, MTA also prevented micro-leakage to a greater extent than 
traditional materials when used for apical restoration. This has been shown by 
investigations using dye, fluid filtration and bacterial infiltration leakage methods. 38 
1.2.2.3 Biocompatibility 
“Biocompatibility refers to the ability of a material to perform with an appropriate host 
response in a specific situation”39. It is well known that a biomaterial should cause no 
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harm to the recipient, which means the material should be non-toxic, non-irritant, 
non-allergenic and non carcinogenic. 40 
When placing materials in to the apex of the root canal it is never really possible to 
avoid contact with the surrounding tissue. So regardless of the dentist‟s precision 
some materials will be in contact with vital tissue. Therefore it must be ensured that 
the material does not cause any harm such as irritation or tissue necrosis.  
Development of an intermediate layer of hard tissue deposition on the materials 
surface would be a positive response aiding in improving the quality of the apical 
seal. The possibility of recurrent infection as a consequence of the presence of 
bacteria at the apex of the tooth is a constant problem in endodontic treatment which 
warrants further research to identify a solution.  
The cytotoxicity of amalgam MTA, ZOE, as well as positive and negative controls 
were investigated in human periodontal ligament fibroblasts after 24 hours41. It was 
observed that both the freshly mixed as well as in the 24 hour set samples the order 
of decreasing cytotoxicity was; amalgam, super-EBA, MTA.40 Lin et al. (2004) found 
that human periodontal ligament fibroblasts mitochondrial dehydrogenase activity 
was not negatively affected by MTA.42 Therefore MTA‟s use in the root apex should 
not elicit any negative response from the periodontal ligament fibroblast.  
A normal morphology and growth of human periodontal ligament fibroblast was found 
with the scanning electron microscopy (SEM) analysis of periodontal ligament 
fibroblast as well as showing attachment to MTA surfaces set for 24 hours.            
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In an investigation carried out by Balto et al. (2003) with freshly mixed MTA samples, 
it was discovered that the human periodontal ligament fibroblasts had a round shape, 
lower density, showed signs of surface defects and lack of attachment to MTA. 43  
Haglund et al. (2003) reported that biocompatibility was shown by the set MTA with 
limited impact on cell growth after 72 hours and no observed effect on cell 
morphology was examined using phase-contrast microscopy.44  
According to Baek et al. (2005), for periapical surgery of obturated canine with 
periapical lesion, MTA induced a favourable healing response of periapical tissue 
compared with amalgam and a ZOE preparation were verified radiographically and 
also in a double-blind histological evaluation. 45  
1.2.2.4 Clinical application of MTA 
Pitt Ford et al. (1996) compared MTA with calcium hydroxide in pulp capping 
treatments in a monkey model, no inflammation was observed in the pulp in which 
MTA was used and 0.43mm continuous dentine bridge formed at five months 
between the pulpal tissues and the cement. These findings were in contrast to 
calcium hydroxide, where a third of all samples displayed dentine bridge formation 
and severe tissue inflammation, determined by histopathological analysis which was 
subjectively performed using light microscopy46. These results regarding comparison 
of MTA with calcium hydroxide were confirmed in a canine model which showed an 
improved tissue response in bridge thickness terms of formation of dentine bridges, 
whilst one third of the calcium hydroxide cases exhibited formation of dentine bridges 
and severe pulpal inflammation47. Human studies of direct pulp capping of teeth, 
comparing MTA and calcium hydroxide application after pulpal exposure in upper 
wisdom teeth at 7days and after 2 to 6months after treatment, were undertaken. The 
calcium hydroxide cases showed tissue inflammation and 0.15mm dentinal bridge 
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thickness at 6months. In contrast, MTA specimens exhibited no tissue reaction with a 
0.28mm dentine bridge at 2months and 0.43mm dentine bridge formation at 6 
months without signs of inflammation48. In a second study with 48 third molars after 
30days the MTA group included 20 teeth with clinical normal pulpal status and 3 
teeth with reversible pulpitis. In contrast, the calcium hydroxide group had 17 teeth 
with normal pulp status, 6 teeth had reversible pulpitis and one exhibited irreversible 
pulpitis49. A histological study of pulpotomy dressings was performed on extracted 
premolar teeth and concluded that MTA induced more continuous dentine bridge 
formation with no inflammation than calcium hydroxide 28 and 56days after 
pulpotomy treatment50.   
A clinical study by Chong et al. (2003) to determine the success rate of MTA and 
ZOE as root end filling materials was undertaken where 122 patients referred for 
endodontic surgery were treated with both ZOE and MTA preparations. No statistical 
differences between MTA and ZOE were found at both the 12- and 24-month 
recalls.51 
Complete healing of repair sites took place in a study using MTA for root perforation 
repair in 16 cases. The cases consisted of 5 lateral root perforations, 5 strip 
perforations, three furcation perforations and three apical perforation, the study thus 
showed MTA being used in a range of perforation situations52. Though the initial 
results were promising, this study presented an incomplete view of MTA as no control 
group was included. However, several other studies showed that MTA used for 
treatment of horizontal root fractures, root resorption and furcation perforation were 
successful clinically and return of normal architecture observed radiographically. 8 
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1.2.2.5 Indications for MTA use 
MTA can be used as root end filling material as it has not been shown to cause 
significant inflammation in the short term and has shown formation of new dentine 
bridges leading to periapical regeneration in the long term. Secondly, MTA can be 
used in immature badly decayed teeth with open apices and with non-vital teeth as 
apical stops53 and for perforation repairs. MTA is a hydrophilic material with a mineral 
substance similar to dentine which makes MTA a suitable repair material especially 
when applied directly after diagnosis of a perforation. Fourthly, MTA can be used as 
a repair for lateral root perforations. Furthermore, MTA has been shown to be an 
option for use as a coronal plug after obturation of the root canal has been 
completed. MTA must be applied into the prepared cavity before whitening of 
discoloured teeth or permanent restoration because of the MTA‟s sealing ability.29 
Finally, MTA can also be utilized as a pulp capping material and for pulpotomies and 
is the most common pulp treatment of the primary teeth before six years of age. The 
absence of micro leakage and bacterial contamination gives a better chance for the 
dental pulp to heal as MTA stimulates the formation of dentine bridges. 54 
1.3 Modifying MTA 
During a surgical procedure in furcal and lateral root perforations, soft tissues will be 
exposed to the endodontic filling material used for repair. There will be for example 
blood which consists of a large number of plasma proteins. Any blood contact with a 
setting material is likely to affect the properties of the endodontic filling including its 
longevity. It is thus crucial to investigate the properties of MTA setting in the 
presence of these plasma proteins and in the present study albumin, fibrinogen and 
gamma globulin were chosen to represent typical plasma proteins found in the 
physiological enviroment.55  
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1.3.1 Albumin 
Of all the plasma proteins, the globular albumin is the most abundant making up 
about 60% of the total serum protein and it is secreted entirely by the liver. Albumin 
plays an important role in maintaining the osmotic pressure of blood and is also 
involved in the transportation of fatty acids, bilirubin, pigments, ions and several 
amino acids. In addition to this, albumin regulates plasma concentrations of 
substances like tryptophan, calcium, steroid hormones and other substances by 
serving as an overflow carrier reservoir when the primary binding proteins become 
saturated.56 The average level of plasma albumin is approximately 35000-45000 
mg/ml and has a molecular weight of 69366.6 kDa (1 kDa = MW 1000) although this 
varies with gender and age; however, this level further decreases with increasing 
age. Clinically normal levels of albumin indicate good health whilst there is a 
reduction in plasma concentration in disease states. In patients suffering from 
nephrotic syndrome the concentration can decrease to levels below 35g/L.56 
 
1.3.2 Fibrinogen 
Another relatively abundant plasma protein is fibrinogen, which has a molecular 
weight of 340,000 kDa and is a large chain fibrous protein. It is easily precipitated as 
a salt and in the coagulation process a multitude of reactions occur whereafter 
fibrinogen, by the release of two fibrinopeptides, is converted into insoluble fibrin.  
The normal concentration of fibrinogen should be between 1900 to 3300 mg/ml, 
whilst most values are usually within 2200-2800 mg/ml. In contrast to albumin these 
values are not affected by age or sex. Hereditary afibrinogenemia (the total absence 
of fibrinogen) is a rare hereditary diseases in which sufferers have little or no 
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fibrinogen in their blood. The blood, as a consequence of the absence of fibrinogen, 
is incapable of coagulation, and hence excessive bleeding similar to that of a 
haemophiliac takes place. On the other hand, high levels of fibrinogen can be found 
in necrotic tissues and in malignant tissues.56 
1.3.3 Gamma-globulin (γ-globulin)  
Gamma-globulin is a widely used term for a class of plasma proteins which consists 
almost entirely of antibody proteins that arise from immunoglobulins (lgs). In the 
blood, the γ-globulin concentration is in the range of 7000-17000 mg/ml and has a 
molecular weight of 150,000 kDa. The immune system uses the protein in cases of 
invasion by unknown objects such as bacteria and viruses to identify and neutralise 
them.55 
As a common feature γ-globulin has a very slow electrophoretic mobility in an 
alkaline buffer. The immunoglobulin concentrations that are given parenterally to 
humans for immune prophylaxis against infectious disease, or for passive antibody 
replacement in humoral immunodeficiency disease are also referred to as γ-globulin. 
γ-globulin is not a new term as its usage can be confirmed from early studies of 
immunology and the development of immonoprophylaxis. The proteins that were 
soluble in dilute salt solution and precipitated at half saturation with ammonium 
sulphate are known as globulins. The globulins were divided into two groups after it 
was discovered that were not all insoluble in water in the absence of salt as it was 
initially assumed. One group was called the „euglobulins‟ (mostly immunoglobulin M, 
IgM) which followed the initial assumption and the other group was called 
„pseudoglobulins‟ (mostly immunoglobulin G, IgG) which had the ability to dissolve 
even if salt was absent. 55,57   
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CHAPTER 2 -  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 MTA model 
The MTA model system was selected to enable laboratory production of a 
reproducible powder mixture with defined properties at an affordable price. The 
model system was modified by plasma protein addition in order to investigate the 
effect of plasma protein admixing on certain properties of the cement and how the 
possible changes may be explained. The cement mixed with all three plasma protein 
and the control without plasma protein were also investigated. The model cement 
consisted of 75wt% Portland cement (Blue Circle Mastercrete; LaFarge, Chilton, UK), 
20wt% bismuth oxide (Bi2O3 ;Acros Organics, Loughborough, UK) and 5wt % calcium 
sulphate hemi-hydrate (Crystacal, Newark, UK).30 All samples were hand-mixed 
using a spatula for 30s at a powder-to-liquid ratio (PLR) of 3g/ml with distilled water 
as the liquid phase.30 
2.1.2 Protein addition 
In this project the intrinsic approach directly applied the protein into the liquid 
component of the model cement system in order to observe the effect of proteins on 
the compressive strength and relative porosity of the cements. The extrinsic 
approach involved placing the cement into a mould where a defined volume of a 
protein containing solution was placed to mimic the conditions in vivo. A high 
concentration of either mixed plasma proteins or bovine serum, which represented 
body fluids, was placed into the mould so that the mould could represent the cavity 
site where MTA would be placed. Consequently, the body fluids would usually 
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combine with and encircle the cement mixture during and after cement setting similar 
to the clinical situation when the cement is placed into a cavity in vivo.  
Three different plasma proteins were chosen to represent different protein 
conformations, namely albumin, γ-globulin and fibrinogen which are the most 
abundant plasma proteins in the human body. These plasma proteins were 
investigated to evaluate the effect of different protein concentrations and time periods 
on the properties of the cements: Albumin from bovine serum (A 2153, Sigma-
Aldrich, UK), fibrinogen from bovine plasma (F 8630, Sigma-Aldrich, UK) and γ-
globulin from bovine blood (G 5009, Sigma-Aldrich, UK). The cement powder 
mixtures were mixed with the liquid phase containing either the normal plasma 
protein concentration (normal 1 [protein]), quarter (0.25 [protein]), (2 [protein]) or 
quadruple the normal plasma protein concentration (4 [protein]) as well as a mixture 
of all three proteins. The cement paste was produced with the liquid phase containing 
distilled water with plasma proteins as shown in table 2.1. 
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Table ‎2.1 Variation of the plasma protein concentration in the liquid phase. 
Protein 
Normal plasma 
concentration58,59 
(mg/ml) 
25% of normal 
plasma 
concentration 
(mg/ml) 
400% of normal 
plasma concentration 
(mg/ml) 
Albumin 50 12.5 200 
(100 for 2 [albumin]a) 
Fibrinogen 3 0.75 12 
γ-globulin 10 2.5 40 
Mixed plasma 
protein (Mixture of 
the three proteins) 
albumin 50 
fibrinogen 3 
γ-globulin 10 
albumin 12.5 
fibrinogen 0.75 
γ-globulin 2.5 
albumin 100 
fibrinogen 12 
γ-globulin 40 
a 2 [albumin] concentration represents 100 mg/ml 
 
The mixture of the three proteins were used in the same concentrations, 0.25 
[protein], 1 [protein] and 4 [protein], except for albumin which could only be admixed 
to a maximum of 2 [albumin] as the cement had a rubbery consistency at higher 
concentration and thus caused difficulties in placing the cement into the mould.  
2.1.3 Cement sample production 
 A Gilson pipette was used to measure the liquid, thereafter the liquid was added to 
the MTA model, then the cement mixture was mixed thoroughly by hand with a  
spatula to produce the cement paste. The cement pastes were packed into a 
cylindrical polytetrafluroethylene (PTFE) mould (6 mm diameter, 12 mm height) and a 
glass slide was placed on top of the cement paste to provide a flat sample and to 
minimize drying out of the surface after filling the mould.  
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The extrinsic procedure adopted involved pipetting 60 microlitres of bovine serum or 
high concentration of mixed plasma proteins at the bottom of the mould and on the 
top of the cement paste following placement in the mould in order for the solution to 
surround and mix with the placed cement paste 
Samples were extracted after 24 hours and then stored in distilled water and left to 
set for 2, 7, 28 and 56 days before testing in order to investigate how cement 
compressive strength and relative porosity developed with time. The mould was 
placed in an incubator at 37±1oC for 24 hours to allow the cement samples (n>7) to 
set sufficiently to be extracted and stored in 20ml distilled water at 37oC.12,30,35 
2.2 Methods  
2.2.1 Compressive strength testing 
Both ends of the samples were examined for voids and damaged surfaces and 
flattend using abrasive papers (Silicone carbide paper 500) to a level where the ends 
were parallel and perpendicular to the long axis of the cylinder in order to prevent any 
movement of the samples and to ensure distribution of the applied force over the 
whole cross-section area when placed in the centre of the lower and upper plates of 
the mechanical testing machine. This was determined by measuring the length of the 
sample using a digital Vernier (4-5687, RS) in three different points from the sample 
and then taking an average. The same being repeated for the diameter of each 
sample. The weight was then measured to determine the wet density of each sample 
by using the formula below.  
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The compressive failure load of the samples was determined using a Universal 
testing machine (Instron 5544, High Wycombe Bucks, UK) with a 10kN load cell at a 
crosshead speed of 1 mm/min.  
To calculate the compressive strength the formula below was used, using the values 
for height, diameter, weight and failure load.  


2)
2
(
)(
widthAverage
LoadFailure
MPastrengtheCompressiv  
 
After failure of samples under loading, all the sample fragments were weighed and 
then dried at room temperature in a dessicator for 2 to 4 weeks to remove water so 
that the dry mass of the fragments could be determined. 
2.2.2 Density and relative porosity measurements 
The strut densities of the powder mixture particles (around 1 g of reactant mixture) 
and fragments of the set cement sample (approximately 1 g of fragments from the 
compressive strength) were determined by the use of helium pycnometry (Accupyc 
1330, Micromeritics, Bedfordshire, UK). Helium is used as it enters the smallest voids 
and pores in the sample and the pycnometer measures the volume of helium per unit 
weight of the sample and with the weight of the sample calculates the strut density of 
the sample. These measurements were performed in order to get an indication of the 
extent of the hydration reaction of the cement powder reactants in the set cement 
structure and therefore the presence of more soluble and denser unreacted powder 
in the structure. 
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The relative porosity (RP) of each cement sample was calculated using the dry 
density (mass/volume) of dried cylindrical sample fragments and the measured strut 
densities according to the formulae:  
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2.2.3 Initial and final setting times 
The initial and final setting times of the cement were measured using the Gilmore 
needles technique. The setting time is defined as the duration of time that elapsed 
from start of mixing to the point when the indentor needle of the Gilmore test failed to 
make an indentation. The initial setting time denotes the end of the workability of the 
cement paste after mixing and the final setting time indicates the hardening of the set 
mass. At a temperature of 23±1oC, the cement paste was prepared and filled in the 
mould. A 113g needle with 0.21mm diameter and 454g needle with 0.11mm diameter 
were used to indent the cement and measurements were repeated every 15 
minutes.37, 62  
2.2.4 Scanning electron microscopy 
The microstructure of the cement fragments was examined using scanning electron 
microscopy (SEM) (JEOL 5300LV SEM, UK) at 20kV in high vacuum mode. SEM 
images at magnifications of 500 and 1500 were captured for both smooth (the 
sample surface in-contact with the mould wall) and rough (the sample fracture 
surface) surfaces 2, 28 and 56 days after preparing the samples. Specimens were 
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sputter coated with gold for 2min, using a deposition current of 25mA, to generate a 
coating thickness of 15nm (K550x super coater, Emitech, UK) for dissipation of 
electrical charge and heat during examination.30, 36, 37 
2.2.5 Energy dispersive X-ray spectroscopy (EDX) 
EDX is an analytical technique used to identify the chemical composition of materials. 
The constituents of the control and the MTA model with 2 [albumin] were identified 
using high vacuum EDX at 20 kV (Philips XL-30 FEG Environmental SEM with 
Oxford Inca EDS). The thin uncoated samples were mounted on an aluminium stub 
and the spot analysis was performed 4 times in different places on the same 
sample.38 
2.2.6 Workability 
The workability was observed and evaluated subjectively with regard to the texture of 
the cements with different admixed plasma protein concentrations and compared 
with the control cement. 
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CHAPTER 3 -  RESULTS 
3.1 Compressive strength  
Compressive strength of MTA model with albumin added at different concentrations
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Fig  ‎3.1.1 A graph showing the mean and standard deviation of the compressive strengths for the control and cements 
supplemented with different concentrations of albumin with time. As the albumin concentration increased the 
compressive strengths decreased. 
  
The compressive strengths of the control samples increased with time stored in 
distilled water (Fig 3.1.1). The MTA model with 0.25 [albumin] increased in 
compressive strength after 2, 7 and 28 days with a further slight decrease on day 56.  
The MTA model with 1 [albumin]  showed no notable difference between the 
compressive strength on day 2 and 7 but strength increased at day 28, whilst by day 
56 there was a decrease in strength. The MTA model with 2 [albumin] showed a 
gradual increase in the compressive strengths from day 2 to day 56. The MTA model 
with 4 [albumin] showed no particular trend, with an increase after 7 days which then 
decreased after 28 days before a final increase after 56 days. In short, albumin 
supplements always caused a decrease in strength compared with the control, with 
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the lowest albumin concentration generating the highest strength of all albumin 
containing cements. 
 
   
Compressive strength of MTA model with γ-globulin  added at different 
concentrations
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Fig  ‎3.1.2 A graph showing the mean and standard deviation of the compressive strengths for the control and cements 
supplemented with different concentrations of γ-globulin with time.  The strength was higher the lower the γ-globulin  
concentration. 
 
 The MTA model with 0.25 [γ-globulin] increased in compressive strength on days 2 
and 7 (Fig 3.1.2). On days 7 and 28 the compressive strengths were similar although 
there was a marked increase in compressive strength on day 56. The MTA model 
with 1 [γ-globulin] and 4 [γ-globulin] increased in compressive strengths from day 2 to 
56, the same trend was observed in the control. Generally the strength was higher 
the lower the γ-globulin  concentration. 
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Compressive strength of MTA model with fibrinogen added at different concentrations 
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Fig  ‎3.1.3 A graph showing the mean and standard deviation of the compressive strength for the control and cements 
supplemented with different concentrations of fibrinogen with time. Fibrinogen supplements always caused a decrease 
in compressive strength at all time points when compared with the control. 
 
The MTA model with 0.25 [fibrinogen] and 1 [fibrinogen] showed a similar pattern of 
compressive strength development especially between days 2 and 28 (Fig 3.1.3) in 
addition on days 56 both concentrations showed a sharp increase. The MTA model 
with 4 [fibrinogen] showed a gradual increase in the compressive strengths as also 
appeared to be the trend for the control. The higher the fibrinogen concentration, the 
lower the initial (2 days) and final compressive strengths (56 days). In short, 
fibrinogen supplements always caused a decrease in compressive strength at all 
time points when compared with the control. 
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Compressive strength of MTA model with mixed proteins added at different 
concentrations
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Fig  ‎3.1.4 A graph showing the mean and standard deviation of the compressive strengths for the control and cements 
supplemented with different concentrations of mixed proteins with time. The higher the mixed proteins concentration, 
the lower the compressive strength. 
 
The MTA model with 0.25, 1 and 4 [mixed protein] increased in compressive strength 
from days 2 to 56 (Fig 3.1.4) which were similar to the trend of the control. However, 
between  28 days to 56 days there was a noticable increases in compressive 
strengths for control and 4 [mixed protein] compared with a slight increase for 0.25 
and 1 [mixed protein], so the higher the mixed proteins concentration, the lower the 
initial (2 days) and final compressive strengths (56 days). 
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Compressive strength of MTA model with extrinsic application of plasma protein and 
bovine serum
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Fig  ‎3.1.5 The mean and standard deviation of compressive strengths with time for the control, cement with extrinsic 
application of plasma protein 4 [mixed protein] and bovine serum. Extrinsic application of 4 [mixed protein] and bovine 
serum always caused a substantial decrease in compressive strength when compared with the control.  
  
The compressive strengths of the control samples increased with time (Fig 3.1.5). 
The MTA model with extrinsic application of 4x [mixed protein] increased in 
compressive strength after 7 and 28 days. The MTA model with bovine serum 
showed a similar pattern of compressive strength development. In short, extrinsic 
application of 4 [mixed protein] and bovine serum always caused a substantial 
decrease in compressive strength when compared with the control.  
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3.2 Relative porosity 
Relative porosities of MTA model with albumin added at different concentrations
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Fig  ‎3.2.1 Mean of the relative porosities for the control and cements supplemented with different concentrations of 
albumin with time. The relative porosities generally trend to decrease with setting time, only for 0.25, 1 and 2 [albumin] 
the relative porosities increased after 56 days. The minimum error of the method is represented by the error bars.  
 
The relative porosities of the control samples decreased gradually with time (Fig 
3.2.1). The MTA model with 0.25, 1 and 2 [albumin] showed a steady decrease in the 
relative porosities on days 2, 7 and 28 whilst on day 56 there was an increase.  The 
MTA model with 4 [albumin] showed a gradual decrease in porosity with time. 
However, on day 2 the relative porosities of the MTA model with 1 and 2 [albumin] 
were notably increased compared with the control. In general the relative porosities 
decreased with setting time, only for 0.25, 1 and 2 [albumin] did the relative porosities 
between 28 and 56 days. 
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Relative porosities of MTA model with γ-globulin  added at different concentrations
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Fig  ‎3.2.2 Mean of the relative porosities for the control and cements supplemented with different concentrations of γ-
globulin with time. The relative porosities decreased with increasing setting time. The minimum error of the method is 
represented by the error bars.  
 
The relative porosity of the MTA model with 0.25, 1 and 4 [γ-globulin] decreased from 
days 2 to 56 (Fig 3.2.2) which were similar to the trend of the control, whilst, there 
was no change in relative porosity between day 28 and 56 for 1 [γ-globulin]. Relative 
porosities for γ-globulin containing cement decreased more slowly than for the 
control after 7 days and after 56 days relative porosities were similar for all cements. 
In short, the relative porosities decreased with increasing setting time. 
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Relative porosities of MTA model with fibrinogen added at different concentrations 
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Fig  ‎3.2.3 Mean of the relative porosities for the control and cements supplemented with different concentrations of 
fibrinogen with time. As a trend, the relative porosities decreased with setting time, except for 0.25 [fibrinogen] which 
showed an initial increase in the 2 days stored sample when compared with the control and other fibrinogen samples. 
The minimum error of the method is represented by the error bars.  
 
The MTA model with 1 and 4 [fibrinogen] decreased in relative porosity from days 2 
to 56 (Fig 3.2.3) which was similar to the trend of the control. However, on day 2 for 
0.25 [fibrinogen] the relative porosities were less than those observed on day 2 for 
the other concentrations. The higher the fibrinogen concentration, the higher were 
the initial relative porosities.  So, the relative porosities decreased with setting time, 
except for 0.25 [fibrinogen] which showed an initial increase in the 2 days stored 
sample when compared with the control and other fibrinogen samples. 
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Relative porosities of MTA model with mixed proteins added at different 
concentrations
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Fig  ‎3.2.4 Mean of the relative porosities for the control and cements supplemented with different concentrations of 
mixed proteins with time. Relative porosities decreased with setting time, only for 4 [mixed protein] the relative 
porosities remained constant between 7 and 56 days. The minimum error of the method is represented by the error bars.  
  
The MTA model with 0.25, 1 and 4 [mixed protein] decreased in relative porosity from 
days 2 to 56 (Fig 3.2.4) which were similar to the trend demonstrated by the control. 
Relative porosities decreased with setting time, only for 4 [mixed protein] the relative 
porosities remained constant between 7 and 56 days. In short, the higher the 
concentration of mixed proteins, the higher the relative porosities. 
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Relative porosities of MTA model with extrinsic application of plasma protein and 
bovine serum
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Fig  ‎3.2.5 Mean of the relative porosities for the control, with extrinsic application of plasma protein 4 [mixed protein] 
and bovine serum with time. For the control and bovine serum there was practically no change whilst for the sample 
with extrinsic application of 4 [mixed protein] there was a decrease in the relative porosity. The minimum error of the 
method is represented by the error bars.  
 
The relative porosities of the samples of control and MTA model with extrinsic 
application of bovine serum demonstrated roughly the same level between 7 and 28 
days (Fig 3.2.5). The MTA model with extrinsic application of 4 [mixed protein] 
showed a decrease in the relative porosities between 7 and 28 days. In short, for 
control and bovine serum there was practically no change whilst for the sample with 
extrinsic application of 4 [mixed protein] there was a decrease in the relative porosity. 
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3.3 Strut density 
The measured strut densities for the controls and with admixed plasma proteins 
ranged between 2.8 g/cm3 for samples incubated with distilled water for 2 days to  
2.5 g/cm3 for samples incubated for 56 days, whilst the strut densities of the MTA 
model with 4 [albumin] stored for 56 days was still 2.68g/cm3 and notably higher 
when compared with the controls and other cements with admixtures.  
3.4 Setting time 
 
Fig  ‎3.4.1 A graph showing the mean and standard deviations of the initial setting times for the control and the cements 
supplemented with different concentrations of plasma proteins added to MTA. Fibrinogen and γ-globulin increased 
setting time (retardants) while albumin acted as an accelerant with increasing concentration.  
There was a notable increase in the initial setting time for MTA with 0.25 [albumin] 
compared with the control (Fig 3.4.1). However as the albumin and mixed proteins 
concentration increased the setting time decreased and 4 [albumin] demonstrated 
the fastest setting compared with all other plasma proteins. On the contrary, as the 
concentration increased for γ-globulin the setting time also increased. 
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There was a decrease in the initial setting time for fibrinogen admixtures compared 
with the control. With increasing concentration, fibrinogen and γ-globulin increased 
setting times while albumin decreased it. So increasing γ-globulin and fibrinogen 
concentrations acted as retardants while albumin was acting as an accelerant. 
3.5 Scanning Electron Microscopy 
  
Fig  ‎3.5.1 SEM secondary electron micrographs 
showing MTA model (control)  set for 2 days that 
represents capillary channels 
Fig  ‎3.5.2 SEM secondary electron micrographs showing 
2 [albumin] set for 2 days that shows small irregular 
particles interspersed by large particles 
            
 The SEM secondary electron micrographs showed small irregular particles 
interspersed with large particles as shown by arrows 2 and 3 in fig. 3.5.2 and 
capillary channels as shown by arrow 1 in fig. 3.5.1. 
 
1 
2 
3 
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Fig ‎3.5.3 SEM secondary electron micrographs 
showing MTA model (control)  set for 56 days 
that illustrates formation of relatively small 
crystals  
 
 Fig  ‎3.5.4 SEM secondary electron 
micrographs showing 2 [albumin] set for 56 
days shows that the crystals were clustered 
together 
 
The SEM secondary electron micrographs showed the formation of relatively small 
crystals, depicted by arrows 4 and 5, that were clustered together figure (3.5.3 and 
3.5.4) 
In summary the microstructures of the control and samples containing different 
concentrations of the plasma protein appeared relatively similar at days 2, 7, 28 and 
56, except that on day 56 there were crystal precipitations observed on the SEM 
micrographs. 
 
3.6 Energy dispersive X-ray spectroscopy 
The EDX analysis for the MTA model and 2 [albumin] incubated for 56 days in 
distilled water indicated the presence of calcium, bismuth, sulphur, silicon, oxygen, 
aluminium and carbon in the smooth surface of the sample. By calculating the sum of 
the molecular weight of calcium sulphate and comparing it with the EDX results 
5 
4 
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reguarding percentage in weight, the needle-like crystals seen with SEM on the 
surface of the MTA model sample were determined to be chemically similar to 
calcium sulphate dihydrate (gypsum). The total molecular weight of gypsum is 172 
consisting of 23 wt% calcium, 19wt% sulphur and 56wt% oxygen. The EDX 
measurements showed 54wt% calcium, 10wt% sulphur, 32 wt% oxygen and the 
remainder being silicon and aluminium. Calcium can stem from other sources and is 
thus abundantly present in the cement, whereas sulphur is only present in the 
calcium sulphate. The sulphur to oxygen ratio (≈ 1:3) of the precipitates was therefore 
used to identify the composition of the precipitates. The theoretical sulphur to oxygen 
ratio of gypsum by weight is 1:3. The precipitates were therefore identified as 
gypsum crystals.   
3.7 Workability 
The workability of the cements compared with the control was subjectively observed 
for the various plasma proteins concentration. The cement pastes that were mixed 
with 1 and 4 [fibrinogen] were very sticky and viscous. The paste mixed with 4 
albumin concentration had a rubbery consistency that was difficult to work with and 
place into the mould. However, the cement paste mixed with 0.25 and 4 [γ-globulin] 
were more fluid especially at high concentrations. On the other hand, the cement 
pastes mixed with different types of plasma proteins at different concentration were 
more workable.     
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CHAPTER 4 -  DISCUSSION 
4.1 Compressive strength and relative porosity 
 
Relative porosity is a measure of the amount of water in the cement pore system 60. 
There are three possible sources of porosity in the cement system, either from the 
unreacted water left from the formation of the cement paste, as a consequence of 
partially dry powder agglomerates (dry spots) and air bubbles which cause air to be 
trapped in the cement paste. The Portland cement manufacturing industry use 
compressive strength as an indicator for the durability and thus potential longevity of 
cements 63. There is a relationship between compressive strength and relative 
porosity which was first proposed by Takashi et al. (1997)64 after a study on 
hardened Portland cement-based systems. It was later discovered that this 
relationship was also valid for other calcium phosphate based-cement systems 65,66. 
The equation below demonstrates this relationship: 30  
                                                                       RPconste
c
RE
CS 



0       
Where CS is the compressive strength, E0 is the modulus of zero porosity 
material, R is the fracture surface energy, c is the critical flaw size and RP is 
the relative porosity. 
 
The relationship between compressive strength and relative porosity is inverse, as 
when the relative porosity decreased the compressive strength increased and this 
was the case for most of the cement samples, as addition of different plasma 
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proteins to the liquid phase decreased the compressive strength and increased the 
relative porosities of the cement. The plasma proteins influenced the properties of the 
MTA model, where the proteins may have covered or coated the powder surfaces by 
adsorbing to the surface and this may be the reason for the altered properties of the 
MTA model. Studies by Xie J et al. (2001) have shown that albumin blocked the 
interaction of Ca2+ and PO4
-3 with water molecule causing the dissolution and 
precipitation of calcium phosphate cement and thus affecting the properties of 
calcium phosphate based-cement systems67. PC setting can potentially be blocked 
by the action of albumin due to it having a similar constituents in the calcium ion. To 
further investigate regarding MTA and show if adsorption of the proteins have taken 
place, a calcium selective electrode could be used. Albumin binds calcium and 
therefore reduces the availability of calcium ions and thus slows down the reaction. 
Therefore if the measurement of the dissolution of particles with time is recorded, a 
comparison could be made to indicate if something goes into solution slower or faster 
depending on what is added to it. If the rate of dissolution of a normal solution is first 
timed, it can act as a base value to compare the dissolution rates with additions to 
the solution and for example whether adding albumin slow down the reaction as in 
the case of adding albumin. This will cause an increase in dissolution time as the 
albumin binds to the calcium and so will indicate that albumin binds to calcium.  
For albumin, γ-globulin and fibrinogen additions, the compressive strength decrease 
was associated with an increase in relative porosities, this behaviour may be 
explained by protein molecules coating the powders. These molecules then may 
have occupied additional space in the cement paste and in turn created pores in the 
hardened cement and thus led to a slight increase in the porosity and an increase in 
the number of defects of the cement matrix. However, this explanation is not 
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supported by the SEM as no evidence of porosity was observed even at a 
magnification of X1500, although microporosity would not necessarily be visible at 
this magnification. The lowest concentration used for all three plasma proteins was 
0.25 [protein] and showed a small decrease of compressive strength compared with 
the control and high relative porosities, whereas the higher concentrations of plasma 
proteins addition showed more obvious decreases in compressive strength 
compared with the control. Compressive strength increased for both the control 
sample and the other concentrations of plasma proteins containing cement with time.  
However, by day 56 there was a decrease in the compressive strength of 0.25 and 1 
[albumin] samples with an obvious increase in relative porosities, with time the 
formation of pores takes place and leads to the decrease in compressive strength 
with both albumin additions as seen (Fig 3.1.1 and Fig 3.2.1), similarly as found with 
calcium phosphate cements by Chauhan et al. (2006). It was found that the 
compressive strength of a calcium phosphate cement with albumin and fibrinogen 
concentration of 0.1wt%, 0.5wt%, 1.0wt% and 10.0wt% decreased with increased 
concentration of albumin and fibrinogen, this was accompanied by increases in 
relative porosities. A decrease in compressive strength was also shown when the 
study was conducted in the presence of albumin, a 0.1wt% albumin concentration 
lead to a reduction of compressive strength by 11% and for albumin concentrations 
of 0.5wt%-10wt% compressive strength decreased by over 40%. Similar decrease of 
compressive strength and increase of relative porosity were seen with fibrinogen. 57  
The extrinsic application of the MTA model into bovine serum and 4 [mixed protein] 
showed a similar pattern of compressive strength development. Extrinsic application 
caused a substantial decrease in compressive strength and increase in relative 
porosities.  
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The explanation for this behaviour could be due to high porosities, which makes the 
cement less homogeneous and introduces a high number of flaws and air bubbles 
which was observed on the fractured surface. These flaws may expand and therefore 
facilitate crack formation in the cement, causing a decrease in the compressive 
strength.  
4.2 Setting time 
The addition of plasma proteins caused obvious changes in the setting times of the 
cement mixture. Addition of 0.25 [albumin] increased the initial setting time, this may 
be because at low concentrations the albumins coats the particles preventing them 
from reacting, therefore slowing the reaction and increasing the setting time. But 
when the concentration increased the setting times decreased. This may be because 
albumin molecules acted as an adhesive material gluing the cement particles 
together and thus decreasing the setting time, or the decrease of initial setting time 
compared with the control that may have been caused by denaturation of albumin 
due to the high pH. However there is no direct evidence in current studies so further 
investigation in this field is required to address this matter. This could be carried out 
by antibody staining of albumin bound to MTA cement particles.68 
Additions of fibrinogen appeared to decrease the initial setting time compared with 
the control, but when the concentration increased the setting times increased. This 
may be because fibrinogen is a fibrous protein with a spiral shaped structure and 
might connect the particles at low concentration and when the fibrinogen 
concentration increased the fibrinogen molecules around the powder particles may 
have prevented wetting of the powder particles and thereby delayed the setting time. 
42 
 
Addition of γ-globulin showed that as the concentration increased the setting reaction 
was delayed. The reason for this may have been due to γ-globulin being a large 
globular structure which allowed a greater surface interaction with the reactant 
powders and thus preventing the wetting of the powders and therefore the setting 
reaction was retarded as the concentration increased. 
For the MTA model mixed with three plasma proteins, the setting times appeared to 
be a combination of these effects. At high concentration albumin dominated thus 
leading overall to a decrease in setting time when compared with the control.    
4.3 Strut density 
The specific densities for all cements ranged between 2.8 g/cm3 for samples 
incubated with distilled water for 2 days to 2.5 g/cm3 for samples incubated for 56 
days. A decrease in the strut densities was observed as the setting time progressed, 
as more water became chemically bound to the set material in the water consuming 
hydration reaction, subsequently compressive strength increased and porosity 
decreased with time. The strut density of the control cements along with all the other 
cements showed similar patterns of development with time when compared to each 
other. However, higher strut densities of the MTA model with 4 [albumin] for 56 days 
were observed when compared with the control and other admixtures. This could 
have been a consequence of the high albumin concentration preventing hydration of 
the cement particles and therefore interfering with the setting reaction even after 56 
days.  
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4.4 SEM  
The microstructure of MTA model samples with or without protein addition appeared 
similar which indicated that there was no apparent change in the structure due to the 
addition of protein for cements with and without protein addition, the structure 
became more dense with increasing setting time for all cements.   
4.5 EDX 
The precipitate formed by EDX could be identified as the calcium sulphate dihydrate 
(gypsum). However, it could not be determined whether this crystal precipitation 
material was generated during the period that the samples of the MTA model were in 
solution or while the samples were in the process of being dried.   
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CHAPTER 5 -  CONCLUSIONS 
This study investigated the influence of three plasma proteins on setting and material 
properties of an MTA-like cement. In the investigation, it was confirmed that the 
decrease in compressive strength was inversely proportional to an increase in 
relative porosity of the cement. It showed that the plasma proteins and an increase in 
their concentration lead to increased porosity of the cement matrix and thus a 
decrease in compressive strength. For albumin, fibrinogen and γ-globulin additions, 
the compressive strength decreased with increasing concentration which weakened 
the cement structure. With respect to the setting time, an increase in γ-globulin and 
fibrinogen concentration retarded the setting while albumin acted as an accelerant. 
The effect of the mixed protein addition appeared to be a combination of the 
individual proteins. The extrinsic addition of bovine serum and the high concentration 
of mixed proteins to the MTA model, caused a substantial decrease in compressive 
strength and increase in relative porosities. It was observed using SEM and 
determined by EDX that the needle-like crystals on the surface of the MTA model 
sample were chemically similar to calcium sulphate dihydrate (gypsum).  
The study indicated that the three plasma protein admixtures tested evidently had a 
substantial effect on the material properties of a Portland cement based cement and 
as such have to be taken into account when developing and investigating such a 
material. 
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